Interferon regulatory factor 1 marks activated genes and can induce target gene expression in systemic lupus erythematosus

Arthritis and Rheumatology

Volumn 67, Issue 3, 2015, Pages 785-796

  Zhang, Zhe ^a   Shi, Lihua ^a   Song, Li ^a   Ephrem, Elshaddai ^a   Petri, Michelle ^b   Sullivan, Kathleen E ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; B CELL ACTIVATING FACTOR; HISTONE H3; INTERFERON REGULATORY FACTOR 1; K RAS PROTEIN; MICA PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; STAT1 PROTEIN; STAT2 PROTEIN; TRANSCRIPTION FACTOR RELA; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CHROMATIN; DNA BINDING PROTEIN; IRF1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; BINDING SITE; BLOOD; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE SEQUENCE; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; MONOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; BIOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; COMPUTATIONAL BIOLOGY; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON REGULATORY FACTOR-1; LUPUS ERYTHEMATOSUS, SYSTEMIC; MONOCYTES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84923640030     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38964     Document Type: Article

References (43)

1. Teichmann LL, Ols ML, Kashgarian M, Reizis B, Kaplan DH, Shlomchik MJ,. Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage. Immunity 2010; 33: 967-78.
2. Banchereau J, Pascual V,. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006; 25: 383-92.
3. Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL,. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med. 1979; 301: 5-8.
4. Pollara G, Handley ME, Kwan A, Chain BM, Katz DR,. Autocrine type I interferon amplifies dendritic cell responses to lipopolysaccharide via the nuclear factor-κB/p38 pathways. Scand J Immunol 2006; 63: 151-4.
5. Testoni B, Vollenkle C, Guerrieri F, Gerbal-Chaloin S, Blandino G, Levrero M,. Chromatin dynamics of gene activation and repression in response to interferon α (IFN[α]) reveal new roles for phosphorylated and unphosphorylated forms of the transcription factor STAT2. J Biol Chem 2011; 286: 20217-27.
6. Garrett S, Dietzmann-Maurer K, Song L, Sullivan KE,. Polarization of primary human monocytes by IFN-γ induces chromatin changes and recruits RNA Pol II to the TNF-α promoter. J Immunol 2008; 180: 5257-66.
7. Chen J, Ivashkiv LB,. IFN-γ abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling. Proc Natl Acad Sci U S A 2010; 107: 19438-43.
8. Foster SL, Hargreaves DC, Medzhitov R,. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007; 447: 972-8.
9. Fang TC, Schaefer U, Mecklenbrauker I, Stienen A, Dewell S, Chen MS, et al. Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response. J Exp Med 2012; 209: 661-9.
10. Yarilina A, Park-Min KH, Antoniv T, Hu X, Ivashkiv LB,. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat Immunol 2008; 9: 378-87.
11. Zhang Z, Song L, Maurer K, Petri MA, Sullivan KE,. Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes. Genes Immun 2010; 11: 124-33.
12. Dornan D, Eckert M, Wallace M, Shimizu H, Ramsay E, Hupp TR, et al. Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53. Mol Cell Biol 2004; 24: 10083-98.
13. Karmali RA, Lauder I, Horrobin DF,. Prolactin and the immune response [letter]. Lancet 1974; 2: 106-7.
14. Peeva E, Michael D, Cleary J, Rice J, Chen X, Diamond B,. Prolactin modulates the naive B cell repertoire. J Clin Invest 2003; 111: 275-83.
15. Petri M,. Sex hormones and systemic lupus erythematosus. Lupus 2008; 17: 412-5.
16. Walker SE,. Bromocriptine treatment of systemic lupus erythematosus. Lupus 2001; 10: 762-8.
17. Alvarez-Nemegyei J, Cobarrubias-Cobos A, Escalante-Triay F, Sosa-Munoz J, Miranda JM, Jara LJ,. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study. Lupus 1998; 7: 414-9.
18. Reilly CM, Olgun S, Goodwin D, Gogal RM Jr, Santo A, Romesburg JW, et al. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice. Eur J Immunol 2006; 36: 1296-308.
19. Pollard KM, Hultman P, Toomey CB, Cauvi DM, Hoffman HM, Hamel JC, et al. Definition of IFN-γ-related pathways critical for chemically-induced systemic autoimmunity. J Autoimmun 2012; 39: 323-31.
20. Crinelli R, Bianchi M, Gentilini L, Magnani M,. Design and characterization of decoy oligonucleotides containing locked nucleic acids. Nucleic Acids Res 2002; 30: 2435-43.
21. Garrett S, Fitzgerald MC, Sullivan KE,. LPS and poly I:C induce chromatin modifications at a novel upstream region of the IL-23 p19 promoter. Inflammation 2008; 31: 235-46.
22. Lee JY, Kim NA, Sanford A, Sullivan KE,. Histone acetylation and chromatin conformation are regulated separately at the TNF α promoter in monocytes and macrophages. J Leukoc Biol 2003; 73: 862-71.
23. Sullivan KE, Reddy AB, Dietzmann K, Suriano AR, Kocieda VP, Stewart M, et al. Epigenetic regulation of tumor necrosis factor α. Mol Cell Biol 2007; 27: 5147-60.
24. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 2012; 7: 562-78.
25. Shi L, Perin JC, Leipzig J, Zhang Z, Sullivan KE,. Genome-wide analysis of interferon regulatory factor I binding in primary human monocytes. Gene 2011; 487: 21-8.
26. Muse GW, Gilchrist DA, Nechaev S, Shah R, Parker JS, Grissom SF, et al. RNA polymerase is poised for activation across the genome. Nat Genet 2007; 39: 1507-11.
27. Shi L, Zhang Z, Yu AM, Wang W, Wei Z, Akhter E, et al. The SLE transcriptome exhibits evidence of chronic endotoxin exposure and has widespread dysregulation of non-coding and coding RNAs. PLoS One 2014; 9: e93846.
28. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003; 4: P3.
29. Huang da W, Sherman BT, Lempicki RA,. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
30. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M,. An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489: 57-74.
31. Porter AC, Chernajovsky Y, Dale TC, Gilbert CS, Stark GR, Kerr IM,. Interferon response element of the human gene 6-16. EMBO J 1988; 7: 85-92.
32. Ramsauer K, Farlik M, Zupkovitz G, Seiser C, Kroger A, Hauser H, et al. Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-γ-inducible gbp2 gene. Proc Natl Acad Sci U S A 2007; 104: 2849-54.
33. Zimmerer JM, Lesinski GB, Radmacher MD, Ruppert A, Carson WE 3rd,. STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-α. Cancer Immunol Immunother 2007; 56: 1845-52.
34. Zhang Z, Song L, Maurer K, Bagashev A, Sullivan KE,. Monocyte polarization: the relationship of genome-wide changes in H4 acetylation with polarization. Genes Immun 2011; 12: 445-56.
35. Seth RB, Sun L, Ea CK, Chen ZJ,. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF 3. Cell 2005; 122: 669-82.
36. Sun Q, Sun L, Liu HH, Chen X, Seth RB, Forman J, et al. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 2006; 24: 633-42.
37. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005; 23: 19-28.
38. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5?-phosphates. Science 2006; 314: 997-1001.
39. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5: 730-7.
40. Boule MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, Rifkin IR,. Toll-like receptor 9-dependent and-independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 2004; 199: 1631-40.
41. Lau CM, Broughton C, Tabor AS, Akira S, Flavell RA, Mamula MJ, et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 2005; 202: 1171-7.
42. Pawar RD, Patole PS, Zecher D, Segerer S, Kretzler M, Schlondorff D, et al. Toll-like receptor-7 modulates immune complex glomerulonephritis. J Am Soc Nephrol 2006; 17: 141-9.
43. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007; 8: 487-96.